Cooperative Agreement 72011120CA00003

This $968,765 Project Grant awarded by the National Science Foundation's (NSF) Division of Mathematical Sciences (CFDA 47.049 - Mathematical and Physical Sciences) will develop a flexible modeling framework to simulate the impact of various testing-based infection control strategies for respiratory pathogens like SARS-CoV-2. The project aims to improve our ability to control existing respiratory diseases and enhance preparedness for future pandemics. Key deliverables include: Developing a...

The Task Force for Global Health, Inc. was awarded a $2,475,519.00 Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) under the Epidemiology and Laboratory Capacity for Infectious Diseases (CFDA 93.323) program. The award, with a performance period from August 1, 2024 to July 31, 2029, supports the Task Force's work in enhancing public health infrastructure for detecting, responding to, preventing, and controlling infectious diseases globally. Key activities...

The Centers for Disease Control and Prevention (CDC) awarded a $3,502,308 Cooperative Agreement under the Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nation's Health program (CFDA 93.421) to The Task Force for Global Health, Inc. The award, effective August 1, 2024 through July 31, 2029, supports the organization's efforts to strengthen public health infrastructure and service delivery across the United States. Key activities...

This federal Cooperative Agreement award, ID NU51CK000371, is funded by the Centers for Disease Control and Prevention (CDC) under the Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nation's Health program (CFDA 93.421). The $567,612 award, effective August 1, 2024 through July 31, 2029, supports the Mississippi State Department of Health (MSDH) in enhancing infectious disease epidemiology, laboratory, and entomology capacity. The key...

This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nation's Health program (CFDA 93.421) provides $274,282 to the American Samoa Department of Health to continue support and capacity building for epidemiology, laboratory, and surveillance activities for infectious diseases in American Samoa. The five-year award, which began on August 1, 2024,...

The National Center for Emerging and Zoonotic Infectious Diseases, a division of the Centers for Disease Control and Prevention (CDC), awarded a $1,105,182 Cooperative Agreement to the Hawaii Department of Health's Children With Special Health Needs - NBS Division. The award, titled "HAWAII'S EPIDEMIOLOGY AND LABORATORY CAPACITY FOR PREVENTION AND CONTROL OF EMERGING INFECTIOUS DISEASES", is funded through the CDC's Emerging Infections Programs (CFDA 93.317) and will run from August 1,...

This $505,746 Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) program (CFDA 93.323) supports the FSM Department of Health and Social Affairs in the Federated States of Micronesia. The award funds a range of public health capacity building activities, including enhancing epidemiological surveillance, laboratory testing capabilities, disease prevention and control programs, and health...

This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Immunization Research, Demonstration, Public Information and Education Training and Clinical Skills Improvement Projects program (CFDA 93.185) provides $2,361,235 to the Georgia Department of Public Health (GDPH) to enhance the state's capacity to detect, respond to, prevent, and control emerging infectious diseases. The funding will enable GDPH to expand its epidemiologic and laboratory...

This $684,241 cooperative agreement awarded by the Centers for Disease Control and Prevention (CDC) under the Emerging Infections Programs (CFDA 93.317) supports the New Hampshire Department of Health & Human Services' (NH DHHS) efforts to strengthen epidemiology and laboratory capacity for the prevention and control of emerging infectious diseases in the state. The award will enable NH DHHS to enhance infectious disease surveillance, outbreak response, data utilization, and collaboration...

The Pennsylvania Department of Health received a $2,906,476 Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the CDC Investigations and Technical Assistance program (CFDA 93.283). The purpose of this 5-year award (8/1/2024 - 7/31/2029) is to enhance the state's capacity to effectively detect, respond, prevent, and control known and emerging infectious disease threats. Key activities include strengthening epidemiologic capacity, enhancing laboratory...